Search results
Found 10537 matches for
Researchers at the MRC Weatherall Institute of Molecular Medicine have recently discovered why a class of cancer drugs is beneficial only in a subset of patients. The results could pave the way for the future development of these drugs, known as PNP-inhibitors, as personalised medicines.
Study with us
Find out more about our 4 year PhD studentships.
Your Rights
Your rights under the General Data Protection Regulation